Prognostic impact of <i> <scp>MYD88</scp> </i> and <i> <scp>CXCR4</scp> </i> mutations assessed by droplet digital polymerase chain reaction in <scp>IgM</scp> monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia-Reference-Cited by-同舟云学术

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

Published:2022-10-09 Issue:2 Volume:200 Page:187-196
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Moreno David F.¹²³^ORCID,López‐Guerra Mónica²³⁴⁵,Paz Sara⁴,Oliver‐Caldés Aina¹²³^ORCID,Mena Mari‐Pau¹²,Correa Juan G.¹²³,Battram Anthony M.¹²³,Osuna Miguel²,Rivas‐Delgado Alfredo²^ORCID,Rodríguez‐Lobato Luis Gerardo¹²³,Cardús Oriol¹²³,Tovar Natalia¹²³,Cibeira María Teresa¹²³,Jiménez‐Segura Raquel¹²³^ORCID,Bladé Joan¹²³,Rosiñol Laura¹²³^ORCID,Colomer Dolors²³⁴⁵,Fernández de Larrea Carlos¹²³^ORCID

Affiliation:

1. Amyloidosis and Myeloma Unit, Department of Hematology Hospital Clínic de Barcelona Barcelona Spain

2. Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) Barcelona Spain

3. Facultat de Medicina i Ciències de la Salut Universitat de Barcelona (UB) Barcelona Spain

4. Hematopathology Unit, Department of Pathology Hospital Clínic de Barcelona Barcelona Spain

5. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain

Funder

Fundación Científica Asociación Española Contra el Cáncer

Janssen Research and Development

Instituto de Salud Carlos III

European Commission

Publisher